血液透析患者血清-透析液钾梯度与短期结局的关联
校正患者差异后,较高钾梯度与全因住院和急诊就诊风险增加呈剂量反应关系,心血管住院呈类似趋势但未达统计学显著性,与死亡无关联。
要点
- 较高血清-透析液钾梯度与全因住院和急诊就诊风险增加独立相关。
- 钾梯度与心血管住院呈类似趋势但未达统计学显著性。
- 钾梯度与死亡无显著关联,可能因事件数较少。
核心结论
- 较高的血清-透析液钾梯度独立 associated 与全因住院和急诊就诊风险增加。
主要发现
- 较高钾梯度与较年轻年龄、较高瘘管使用率、较低共病评分和较好营养指标相关。
- 校正患者差异后,较高钾梯度与全因住院和急诊就诊风险增加呈剂量反应关系。
- 心血管住院呈类似趋势但未达统计学显著性。
- 与死亡无关联,可能因事件数较少。
临床怎么用
- 透析前血清-透析液钾梯度较高者可能需关注全因住院和急诊就诊风险。
局限性
- 回顾性设计。
- 死亡事件数较少。
- 需进一步研究减少钾梯度的干预是否改善风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A high serum-to-dialysate potassium (K+) gradient at the start of dialysis leads to rapid lowering of serum K+ and may confer a greater risk of adverse events. Here, we examined the near-term association of K+ gradient with clinical outcomes. METHODS: This retrospective (2010-11) event-based study considered 830 741 patient-intervals, each defined by a pre-dialysis measurement of serum K+ made among adult Medicare Parts A and B enrollees who received in-center hemodialysis on a Monday/Wednesday/Friday schedule at a large US dialysis organization. K+ gradient was considered based on the difference in K+ concentration (serum-dialysate) on the date of measurement; analyses accounted for multiple observations per patient. Outcomes considered were: all-cause and cardiovascular hospital admissions, emergency department (ED) visits and deaths. RESULTS: Higher K+ gradient was associated with younger age, greater fistula use, lower comorbidity scores and better nutritional indices. Adjusting for patient differences, there was a dose-response relationship between higher K+ gradient and greater risks of all-cause hospitalization and ED visit. A similar trend was seen for cardiovascular hospitalization but did not achieve statistical significance. No associations were observed with mortality, potentially due to a low number of events. CONCLUSIONS: Higher K+ gradient is independently associated with greater risk of all-cause hospitalizations and ED visits. Further research is needed to determine whether interventions that reduce the K+ gradient ameliorate this risk.
引用
- Brunelli SM, Spiegel DM, Du Mond C, et al. Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients. Nephrol Dial Transplant. 2018. PMID: 28992343. doi:10.1093/ndt/gfx241
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。